- August 7, 2020
- Category: Consumer Goods and Services, Other Industry Reports
Global Smart Insulin Pen Market By Product (Second Generation Pens,-Bluetooth-Enabled, USB Connected; First Generation), Usability (Reusable, Prefilled), End User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings) and Regional Forecasts 2021-2027
Chapter 1.Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million) 1.2.1. Smart Insulin Pen Market, by Region, 2019-2027 (USD Million) 1.2.2. Smart Insulin Pen Market, by Product,2019-2027 (USD Million) 1.2.3. Smart Insulin Pen Market, by Usability,2019-2027 (USD Million) 1.2.4. Smart Insulin Pen Market, by End-user,2019-2027 (USD Million) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Smart Insulin Pen Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Smart Insulin Pen Market Dynamics 3.1. Smart Insulin Pen Market Impact Analysis (2019-2027) 3.1.1. Market Drivers 188.8.131.52. Increase in Polygenic Disorder 184.108.40.206. Future go far Beyond Memory Storage 3.1.2. Market Challenges 220.127.116.11. Strict Product Approval Process 18.104.22.168. High Manufacturing Costing 3.1.3. Market Opportunities 22.214.171.124. Establishing Online Distribution Channels Chapter 4. Global Smart Insulin Pen MarketIndustry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Smart Insulin Pen Market, by Product 5.1. Market Snapshot 5.2. Global Smart Insulin Pen Market by Product, Performance - Potential Analysis 5.3. Global Smart Insulin Pen Market Estimates & Forecasts by Product2018-2027 (USD Million) 5.4. Smart Insulin Pen Market, Sub Segment Analysis 5.4.1. Second Generation pens 5.4.2. USB Connected Smart Insulin pens 5.4.3. Bluetooth-Enabled Smart Insulin pens 5.4.4. First Generation pens Chapter 6. Global Smart Insulin Pen Market, byUsability 6.1. Market Snapshot 6.2. Global Smart Insulin Pen Market by Usability, Performance - Potential Analysis 6.3. Global Smart Insulin Pen Market Estimates & Forecasts by Usability2018-2027 (USD Million) 6.4. Smart Insulin Pen Market, Sub Segment Analysis 6.4.1. Pre-Filled Smart Insulin Pen 6.4.2. Reusable Owned Smart Insulin Pen Chapter 7. Global Smart Insulin Pen Market, by End-user 7.1. Market Snapshot 7.2. Global Smart Insulin Pen Market by End-user, Performance - Potential Analysis 7.3. Global Smart Insulin Pen Market Estimates & Forecasts by End-user 2018-2027 (USD Million) 7.4. Smart Insulin Pen Market, Sub Segment Analysis 7.4.1. Hospitals and clinic 7.4.2. Ambulatory surgical centers 7.4.3. Home care settings Chapter 8. Global Smart Insulin Pen Market, Regional Analysis 8.1. Smart Insulin Pen Market, Regional Market Snapshot 8.2. North America Smart Insulin Pen Market 8.2.1. U.S. Smart Insulin Pen Market 126.96.36.199. Productbreakdown estimates & forecasts, 2018-2027 188.8.131.52. Usabilitybreakdown estimates & forecasts, 2018-2027 184.108.40.206. End-userbreakdown estimates & forecasts, 2018-2027 8.2.2. Canada Smart Insulin Pen Market 8.3. Europe Smart Insulin Pen Market Snapshot 8.3.1. U.K. Smart Insulin Pen Market 8.3.2. Germany Smart Insulin Pen Market 8.3.3. France Smart Insulin Pen Market 8.3.4. Spain Smart Insulin Pen Market 8.3.5. Italy Smart Insulin Pen Market 8.3.6. Rest of Europe Smart Insulin Pen Market 8.4. Asia-Pacific Smart Insulin Pen Market Snapshot 8.4.1. China Smart Insulin Pen Market 8.4.2. India Smart Insulin Pen Market 8.4.3. Japan Smart Insulin Pen Market 8.4.4. Australia Smart Insulin Pen Market 8.4.5. South Korea Smart Insulin Pen Market 8.4.6. Rest of Asia Pacific Smart Insulin Pen Market 8.5. Latin America Smart Insulin Pen Market Snapshot 8.5.1. Brazil Smart Insulin Pen Market 8.5.2. Mexico Smart Insulin Pen Market 8.6. Rest of The World Smart Insulin Pen Market Chapter 9. Competitive Intelligence 9.1. Top Market Strategies 9.2. Company Profiles 9.2.1. Companion Medical Inc. 220.127.116.11. Key Information 18.104.22.168. Overview 22.214.171.124. Financial (Subject to Data Availability) 126.96.36.199. Product Summary 188.8.131.52. Recent Developments 9.2.2. Digital Medics Ptd Ltd. 9.2.3. Eli Lilly and Company 9.2.4. Novo Nordisk A/S 9.2.5. Diamesco Co., Ltd. 9.2.6. F. Hoffmanna-La Roche AG 9.2.7. Insulet Corporation 9.2.8. Emperra GmbH E-Health Technologies 9.2.9. Jiangsu Delfu Medical Device Co. Ltd. 9.2.10. Bigfoot Biomedica Chapter 10. Research Process 10.1. Research Process 10.1.1. Data Mining 10.1.2. Analysis 10.1.3. Market Estimation 10.1.4. Validation 10.1.5. Publishing 10.2. Research Attributes 10.3. Research Assumption
Global Smart Insulin Pens s valued approximately USD 89.53 million in 2020and is anticipated to grow with a healthy growth rate of more than 10.77% over the forecast period 2021-2027.Diabetes is a major health problem that is rapidly increasing in the global population; therefore, the use of good internal secretion pens is significantfor the safe and effective administration of internal secretion to individuals suffering from polygenic disorder. Internal secretion pens are used to deliver internal secretion outwardly, provides higher polygenic diabetes management system. The increase in polygenic disorder cases boost the market growth. One of the key factors working in favour of the global market is the growing number of diabetics as a result of obesity, inactive lifestyles, and ageing. Fatness has emerged as one of the leading causes of polygenic disorder in people. Undernutrition are the first links to polygenic disorder cases, which are increasing at epidemic proportions. As a result of the large number of people affected by polygenic disorder, the market for sensible internal secretion pens is expanding globally.Smart insulin pens support in calculating personalized doses, continuously tracking glucose, and connecting with smartphone apps to visualize data. Moreover, Novo Nordisk and Abbott collaborated in 2019 to integrate insulin dose data into digital health tools, with the goal of connecting key technologies such as continuous glucose monitoring and insulin pen market size worldwide.Strict government regulations and high cost are the restraining factors of the market. North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa make up the global smart insulin pens industry. North America is the industry leader for smart insulin pens, accounting for more than half of overall sales in 2017. Furthermore, North America generates the most sales due to the involvement of major players and a high rate of adoption of technologically advanced products. Furthermore, Asia Pacific is expected to expand rapidly over the forecast period. This is due to a rise in the number of geriatrics with diabetes, which is fueling the growth of the smart insulin pens market in this area.
Major market player included in this report are:
Companion Medical Inc.
Digital Medics Ptd Ltd.
Eli Lilly and Company
Novo Nordisk A/S
Diamesco Co., Ltd.
F. Hoffmann-La Roche AG
Emperra GmbH E-Health Technologies
Jiangsu Delfu medical device Co. Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Second Generation Pens
USB Connected Smart Insulin Pen
Bluetooth-Enabled Smart Insulin Pen
First Generation Pens
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Home care settings
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Smart Insulin Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers